Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Talabostat in Patients With Metastatic Renal Cell Carcinoma

NCT00489710 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00489710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00489710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Talabostat in Patients With Metastatic Renal Cell Carcinoma
Lead sponsor
University of Nebraska
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2006
Completion date
May 30, 2007
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer